August 14, 2024

ADC as a quantitative value: classifying lymph node dignity in prostate cancer and inter-scanner variability

Key Points

Key points are not available for this paper at this time.

Abstract

Apparent diffusion coefficient (ADC) has potential as a quantitative imaging biomarker for differentiation of malignant from benign tissue. Here, we present a phantom and in vivo measurement of ADC reproducibility and a restrospective study in over 100 patients with prostate cancer to evaluate ADC as a classifier.

Bookmark

Cite This Study

Bauer et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5c521b6db64358755b8ca https://doi.org/https://doi.org/10.58530/2023/1858

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The apparent diffusion coefficient as a biomarker in the diagnosis of cervical cancer and the assessment of therapeutic response to chemoradiation therapy2025 · 3 citations
2The value of apparent diffusion coefficient values in predicting Gleason grading of low to intermediate-risk prostate cancer2024 · 11 citations
3Apparent diffusion coefficient values in prostate cancer: Association with pathological grade groups and correlation with Ki-67 proliferation index2026
4Studying variation in DWI MRI derived ADC for Prostate Cancer (PCa) with respect to Gleason Grade and location of PCa lesions2024
5Correlation of MRI-Derived Apparent Diffusion Coefficient (ADC) Values With Gleason Scores in Prostate Cancer and Quantitative Prostate MRI Reading2026 · 1 citations

Bookmark